296766-71-7

Basic information

• Product Name: (1S,2R)-N-[2-hydroxy-1-(hydroxymethyl)propyl]benzamide
• Synonyms: (1S,2R)-N-[2-hydroxy-1-(hydroxymethyl)propyl]benzamide
• CAS NO: 296766-71-7
• Molecular Weight: 209.245
• Mol File: 296766-71-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (1S,2R)-N-[2-hydroxy-1-(hydroxymethyl)propyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,2R)-N-[2-hydroxy-1-(hydroxymethyl)propyl]benzamide(296766-71-7)
• EPA Substance Registry System: (1S,2R)-N-[2-hydroxy-1-(hydroxymethyl)propyl]benzamide(296766-71-7)

Safety Data

• Hazardous Substances Data: 296766-71-7(Hazardous Substances Data)

Upstream product

• 79893-89-3 N-benzoyl-L-threonine methyl ester 

Downstream Products

• 296766-60-4 N,N'-methylenebis[(2S,4R,5R)/(2S,4S,5S)-4-methyl-1,3-dioxan-2,5-diyl]bisbenzamide 
• 296766-50-2 [(2S,4R,5R)-N-2-(2,2-dimethoxyethyl)-4-methyl-1,3-dioxan-5-yl]benzamide 

Relevant articles and documents

Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes

A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compounds were tested using the xylene-induced mouse ear edema model. Some of these compounds exhibited comparable or better anti-inflammatory activities than that of aspirin suggesting that they can be further developed as potential anti-inflammatory drug lead compounds. In addition, treatment of these anti-inflammatory agents did not prolong tail bleeding time in mice. The structure/activity relationships were also analyzed among these compounds.